Christophe Van Huffel
Christophe Van Huffel is an accomplished biotech leader with over 20 years of experience in the life sciences, specializing in business development, strategy optimization, and innovation in cancer therapies. He is the co-founder and Chief Scientific Officer of OncoRNA and has played a key role in securing major funding and advancing cutting-edge personalized immunotherapies.
Throughout his career, Christophe has held senior roles at multiple companies, including OncoDNA, where he led North American pharma business development, and GENERGON, a consulting firm he founded to support biotech and pharma companies with international growth strategies. He has also served as a Business Growth Adviser for myNEO and as an interim CEO for Persomed life sciences.
Christophe holds a PhD in Chemistry from Université libre de Bruxelles and completed further education in management at the Solvay Brussels School of Economics and Management. His broad expertise spans from management and strategy to scientific innovation, contributing significantly to the advancement of personalized medicine and oncology solutions.